Your shopping cart is currently empty

J-1149 is a potent ALK5 inhibitor with an IC50 value of 0.017 μM. Additionally, it exhibits weaker inhibition of p38αMAP kinase, showing an IC50 value of 0.435 μM. J-1149 is applicable in liver fibrosis research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | J-1149 is a potent ALK5 inhibitor with an IC50 value of 0.017 μM. Additionally, it exhibits weaker inhibition of p38αMAP kinase, showing an IC50 value of 0.435 μM. J-1149 is applicable in liver fibrosis research. |
| Targets&IC50 | ALK5:0.017 μM |
| In vitro | J-1149 (compound 15g) (5-40 μM, 24 h) effectively inhibits the TGF-β-induced extracellular matrix (ECM) deposition in hepatic stellate cells (HSC), ultimately suppressing HSC activation. Additionally, J-1149 (20 μM, 24 h) reduces the expression of TGF-β-stimulated α-SMA and collagen I. |
| In vivo | J-1149 (compound 15g) administered orally at a dose of 15 mg/kg demonstrates favorable pharmacokinetic (PK) properties and exhibits a good half-life (t 1/2 = 9.14 h). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.